Novitium Pharma Company Profile
What is the competitive landscape for NOVITIUM PHARMA
NOVITIUM PHARMA has one hundred and nineteen approved drugs.
There are three US patents protecting NOVITIUM PHARMA drugs.
Summary for Novitium Pharma
| US Patents: | 3 |
| Tradenames: | 104 |
| Ingredients: | 103 |
| NDAs: | 119 |
| Patent Litigation for Novitium Pharma: | See patent lawsuits for Novitium Pharma |
Drugs and US Patents for Novitium Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novitium Pharma | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 215604-004 | Oct 5, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novitium Pharma | CLOBAZAM | clobazam | TABLET;ORAL | 209308-002 | Oct 22, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Novitium Pharma | IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 205990-002 | Feb 8, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Novitium Pharma | L-GLUTAMINE | l-glutamine | FOR SOLUTION;ORAL | 215647-001 | Jul 8, 2024 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novitium Pharma | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 202710-001 | Jun 10, 2013 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novitium Pharma | TADALAFIL | tadalafil | TABLET;ORAL | 215949-003 | Mar 3, 2023 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
